144 related articles for article (PubMed ID: 6187504)
1. Anti-keratin antibodies in rheumatoid arthritis: frequency and correlation with other features of the disease.
Mallya RK; Young BJ; Pepys MB; Hamblin TJ; Mace BE; Hamilton EB
Clin Exp Immunol; 1983 Jan; 51(1):17-20. PubMed ID: 6187504
[TBL] [Abstract][Full Text] [Related]
2. Significance of antikeratin antibodies in rheumatoid arthritis.
Hajiroussou VJ; Skingle J; Gillett AP; Webley M
J Rheumatol; 1985 Feb; 12(1):57-9. PubMed ID: 2580092
[TBL] [Abstract][Full Text] [Related]
3. Reactivity of serum antibodies to the keratin layer of rat esophagus in patients with rheumatoid arthritis.
Quismorio FP; Kaufman RL; Beardmore T; Mongan ES
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S69-74. PubMed ID: 18240220
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of antikeratin antibodies in rheumatoid arthritis.
Ordeig J; Guardia J
J Rheumatol; 1984 Oct; 11(5):602-4. PubMed ID: 6210364
[TBL] [Abstract][Full Text] [Related]
5. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A
Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426
[TBL] [Abstract][Full Text] [Related]
6. [Significance of citrullinated collagen type II and its antibodies in rheumatoid arthritis].
Tian X; Bi LQ; Li ZG
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(33):2334-8. PubMed ID: 17156630
[TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A in the assessment of early inflammatory arthritis.
Cunnane G; Grehan S; Geoghegan S; McCormack C; Shields D; Whitehead AS; Bresnihan B; Fitzgerald O
J Rheumatol; 2000 Jan; 27(1):58-63. PubMed ID: 10648018
[TBL] [Abstract][Full Text] [Related]
8. [Comparative characteristics of specific autoantibodies in rheumatoid arthritis].
Lapin SV; Maslianskiĭ AL; Mazurov VI; Totolian AA
Ter Arkh; 2005; 77(12):53-9. PubMed ID: 16514821
[TBL] [Abstract][Full Text] [Related]
9. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
De Rycke L; Verhelst X; Kruithof E; Van den Bosch F; Hoffman IE; Veys EM; De Keyser F
Ann Rheum Dis; 2005 Feb; 64(2):299-302. PubMed ID: 15166003
[TBL] [Abstract][Full Text] [Related]
10. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate.
Mallya RK; de Beer FC; Berry H; Hamilton ED; Mace BE; Pepys MB
J Rheumatol; 1982; 9(2):224-8. PubMed ID: 7097681
[TBL] [Abstract][Full Text] [Related]
11. [The comparison of clinical features between early rheumatoid arthritis and established rheumatoid arthritis].
Furuta E; Suenaga Y; Hashimoto M; Shiokawa S; Nonaka S; Wada T; Yasuda M; Shingu M; Nobunaga M
Ryumachi; 1994 Jun; 34(3):594-600. PubMed ID: 8052925
[TBL] [Abstract][Full Text] [Related]
12. Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection.
Kessel A; Rosner I; Zuckerman E; Golan TD; Toubi E
J Rheumatol; 2000 Mar; 27(3):610-2. PubMed ID: 10743797
[TBL] [Abstract][Full Text] [Related]
13. Anti-keratin antibodies in patients with rheumatoid arthritis.
Sharma BL; Rani R; Misra R; Aggarwal A
Indian J Med Res; 2000 Jun; 111():215-8. PubMed ID: 10969490
[TBL] [Abstract][Full Text] [Related]
14. [Serological profile in so-called seronegative rheumatoid arthritis].
Moineau MP; Youinou P; Le Goff P; Ferec C; Miossec P; Brousse A; Le Saout J
Rev Rhum Mal Osteoartic; 1984 Feb; 51(2):91-5. PubMed ID: 6200919
[TBL] [Abstract][Full Text] [Related]
15. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process.
Aho K; von Essen R; Kurki P; Palosuo T; Heliövaara M
J Rheumatol; 1993 Aug; 20(8):1278-81. PubMed ID: 7693940
[TBL] [Abstract][Full Text] [Related]
16. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
Wolfe F
J Rheumatol; 1997 Aug; 24(8):1477-85. PubMed ID: 9263138
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F
J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
[TBL] [Abstract][Full Text] [Related]
18. Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis.
Grootenboer-Mignot S; Nicaise-Roland P; Delaunay C; Meyer O; Chollet-Martin S; Labarre C
Scand J Rheumatol; 2004; 33(4):218-20. PubMed ID: 15370715
[TBL] [Abstract][Full Text] [Related]
19. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
20. [Anti-keratin antibodies. A marker of progressive rheumatoid arthritis].
Meyer O; Fabregas D; Cyna L; Ryckewaert A
Rev Rhum Mal Osteoartic; 1986 Nov; 53(11):601-5. PubMed ID: 2441453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
